...
首页> 外文期刊>Journal of child neurology >Adrenocorticotropic Hormone Versus Prednisolone in the Treatment of Infantile Spasms Post Vigabatrin Failure
【24h】

Adrenocorticotropic Hormone Versus Prednisolone in the Treatment of Infantile Spasms Post Vigabatrin Failure

机译:肾上腺皮质激素与泼尼松龙治疗婴儿痉挛术后vigabatrin失败

获取原文
获取原文并翻译 | 示例

摘要

The Child Neurology Society/American Academy of Neurology practice parameter has recommended adrenocorticotropic hormone or vigabatrin in the short-term treatment of infantile spasms. When vigabatrin is unavailable or ineffective and adrenocorticotropic hormone is not a treatment option because of the prohibitive cost, other forms of corticosteroids have been considered in the treatment of infantile spasms. This retrospective study reviewed the Hospital for Sick Children's experience with the short-term effectiveness of prednisolone versus adrenocorticotropic hormone in patients with infantile spasms who have failed vigabatrin. The results showed that while adrenocorticotropic hormone was more likely to lead to short-term spasm freedom, there was no difference in the likelihood of longer-term spasm resolution without relapse. These findings can guide clinicians in the treatment of infantile spasms post vigabatrin failure.
机译:儿童神经学社会/美国神经病学实践参数已经推荐了肾上腺皮质激素或Vigabatrin在短期治疗婴儿痉挛。 当Vigabatrin无法使用或无效并且肾上腺皮质激素由于令人望远的成本而不是治疗期权时,在治疗婴儿痉挛时已经考虑了其他形式的皮质类固醇。 此回顾性研究审查了病人儿童的经验,患有失败的婴儿痉挛患者的泼尼松龙与肾上腺皮质激素的短期有效性。 结果表明,虽然肾上腺皮质激素更容易导致短期痉挛自由度,但长期痉挛分辨率的可能性没有差异而不会复发。 这些发现可以指导临床医生治疗婴儿痉挛术后患者失败。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号